COVID-19 mRNA vaccination leading to CNS inflammation: a case series

COVID-19 mRNA vaccination leading to CNS inflammation: a case series

The availability of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provides hope towards mitigation of the coronavirus disease 2019 (COVID-19) pandemic. Vaccine safety and efficacy has not been established in individuals with chronic autoimmune diseases such as mu...

Full description

Bibliographic Details
Main Authors: Bakshi, R. (Author), Bhattacharyya, S. (Author), Bruso, P. (Author), Edwards, K.R (Author), Harrison, D. (Author), Houtchens, M.K (Author), Katz, J. (Author), Khayat-Khoei, M. (Author), Tauhid, S. (Author)
Format: Article
Language:English
Published: Springer Science and Business Media Deutschland GmbH 2022
Subjects:
adult
Adult
afferent pupillary defect
Article
ataxic gait
beta1a interferon
carditis
cerebrospinal fluid cytology
cervical spinal cord
clinical article
coronavirus disease 2019
COVID-19
COVID-19 Vaccines
demyelination
Demyelination
drug megadose
dysmetria
elasomeran
Expanded Disability Status Scale
female
Female
fingolimod
follow up
gadolinium
human
Humans
inflammation
Inflammation
limb weakness
male
messenger RNA
methylprednisolone
middle aged
Middle Aged
multiple sclerosis
Multiple sclerosis
myelooptic neuropathy
natalizumab
nervous system inflammation
neuroimaging
neurologic disease
neurologic examination
Neuromyelitis optica
nuclear magnetic resonance imaging
optic neuritis
paresthesia
plasma exchange
prednisone
prospective study
RNA, Messenger
SAR-CoV-2
SARS-CoV-2
tozinameran
vaccination
Vaccination
visual acuity
visual impairment
young adult
Young Adult
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items